No. |
Product Name |
CAS No. |
Spec |
Price |
|
| CI-07337 |
Fmoc-homocyclohexyl-D-alanine ≥ 98% (HPLC) |
269078-72-0 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-07346 |
Fmoc-(2S,4S)-4-phenylpyrrolidine-2-carboxylic acid ≥ 97% (HPLC) |
269078-71-9 |
| 25MG |
Inquiry |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-07344 |
Fmoc-(2R,5S)-5-phenylpyrrolidine-2-carboxylic acid |
269078-69-5 |
| 25MG |
Inquiry |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-11625 |
Fmoc-S-4-methyltrityl-L-cysteine ≥ 99% (HPLC) |
269067-38-1 |
| 1G |
Inquiry |
| 5G |
Inquiry |
| 25G |
Inquiry |
|
|
| CI-03695 |
Fmoc-L-aspartic acid β-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino]benzyl ester ≥ 98% (HPLC) |
269066-08-2 |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
| 25G |
Inquiry |
|
|
| CI-08079 |
Nα-Fmoc-Nδ-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-L-ornithine ≥ 99% (HPLC) |
269062-80-8 |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-11185 |
Fmoc-Nε-2,4-dinitrophenyl-D-lysine ≥ 99% (HPLC) |
269061-41-8 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
|
|
| CI-11185 |
Fmoc-Nε-2,4-dinitrophenyl-D-lysine ≥ 99% (HPLC) |
269061-41-8 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
|
|
| CI-03756 |
Fmoc-3-(9-anthryl)-L-alanine ≥ 99% (HPLC) |
268734-27-6 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
|
|
| CI-07412 |
Fmoc-3-(9-anthryl)-D-alanine ≥ 98% (HPLC) |
268733-63-7 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
|
|
| CI-07350 |
Fmoc-D-1,2,3,4-tetrahydronorharman-3-carboxylic acid |
268731-07-3 |
|
|
| CI-07409 |
Fmoc-4-(Boc-aminomethyl)-D-phenylalanine 98+% |
268731-06-2 |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-03706 |
Fmoc-L-glutamic acid γ-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino] benzyl ester ≥ 98.5% (HPLC) |
268730-86-5 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
| 25G |
Inquiry |
|
|
| CI-05701 |
Fmoc-O-tert-butyl-D-trans-4-hydroxyproline 99% |
268729-12-0 |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-11176 |
Nα-Fmoc-Nω,ω-dimethyl-L-arginine (asymmetrical) hydrochloride ≥ 98% (HPLC) |
268564-10-9 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-04955 |
Fmoc-(3S,4S)-4-amino-3-hydroxy-6-methylthio-hexanoic acid ≥ 97% (HPLC) |
268542-18-3 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
|
|
| CI-07333 |
(S)-N-4-Fmoc-N-8-Boc-diaminooctanoic acid ≥ 99% (HPLC) |
268542-17-2 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-07308 |
Fmoc-(R)-3-aminoadipic acid-α-tert-butyl ester ≥ 98% (HPLC) |
268542-16-1 |
| 100MG |
Inquiry |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-09984 |
β-S-(4-Methoxybenzylmercapto)isovaleric acid ≥ 99% (TLC) |
268219-99-4 |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
| CI-07372 |
(R,S)-1,3,4,5-Tetrahydro-5-phenyl-2H-1,4-benzodiazepin-2-one hydrochloride ≥ 98% (HPLC) |
268209-92-3 |
| 250MG |
Inquiry |
| 1G |
Inquiry |
| 5G |
Inquiry |
|
|
